Titan Pharmaceuticals, Inc. (TTNP) stock price traded with dropping change along with the volume 1.2 million shares in Thursday trading session. Shares are trading price at $0.24 with move of -7.34%. The company’s 3-months average volume stands at 9.7 million. When we divide the last trade volume by the 3-month average volume, we found out a relative volume of 0.12. Recent trade price levels places TTNP’s stock about -83.45% away from the 52-week high and closed 39.53% away from the 52-week low. The total dollar value of all 66.54 million outstanding shares is 0.02 billion. EPS growth in past 5 year was 11.70% along with sales growth of -50.30% in the last five years. EPS growth in next year is estimated to reach 43.30% while EPS growth estimate for this year is set at -382.00%.
5.70% shares of the company possessed by Institutional Investors. Insiders own 3.10% of Titan Pharmaceuticals, Inc. (TTNP) shares. During last six month record, the net percent change kept by insiders has observed a change of 133.67%. The stock volatility for week was 12.43% while for month was 11.00%.
Return on Assets (ROA) ratio indicates how profitable a company is relative to its total assets. The ROA is -123.40%. A company that manages their assets well will have a high return, while if manages their assets poorly will have a low return.
Common shareholders want to know how profitable their capital is in the businesses they invest it in. The company gives a ROE of -904.10%. The higher the ROE, the better the company is at generating profits.
ROI is -193.40%. A positive result means that returns exceed costs. Analysts therefore consider the investment a net gain. The opposite kind of result, a negative means that costs outweigh returns. Analysts therefore view the investment as a net loss.
Titan Pharmaceuticals, Inc. (TTNP) recently closed with fall of -4.82% to its 20-Day Simple Moving Average. This short time frame picture represents a downward movement of current price over average price of last 20 days. Now moving toward intermediate time frame, 50-day Moving average is more useful at showing position trading trends lasting 50 days. Shares of TTNP moved downward with change of -24.60% to its 50-day Moving average. This falling movement shows negative prices direction over last 50 days.
Finally observing long term time frame, 200-day simple moving average is more helpful at telling general investing trends lasting 200 days. Longer moving average timeframes are less sensitive to price fluctuations than shorter term timeframes and will generate far few signals. This will reduce the number of “whipsaws”, which is good, but will also generate signals later than when using shorter term averages. TTNP stock price revealed pessimistic move of -63.73% comparing average price of last 200 days. This comparison showed down direction of price behind its 200-SMA.
ATR value of company was 0.03. Average True Range (ATR) is an indicator based on trading ranges smoothed by an N-period exponential moving average percentage of the true range values. ATR can display volatility of stocks, ETFs and indexes. The principal of ATR is very similar to other volatility indicators: A high ATR value signals a possible trend change. A low ATR value correlates with a weaker trend movement.
The price to sales ratio is 2.96. The lower price P/S ratio indicates attractive the investment. A low P/S can also be effective in valuing growth stocks that have suffered a temporary setback. A low P/S ratio may indicate possible undervaluation, while a ratio that is significantly above the average may suggest overvaluation. Abbreviated as the P/S ratio or PSR, this ratio is also known as a “sales multiple” or “revenue multiple.”
Albert has over 14 years experience in the financial services industry giving him a vast understanding of how news affects the financial markets. He is an active day trader spending the majority of his time analyzing earnings reports and watching commodities and derivatives. He has a Masters Degree in Economics from Westminster University with previous roles counting Investment Banking.